← Back to Search

AgingPLUS for Physical Activity

N/A

Waitlist Available

Led By Manfred K. Diehl, PhD

Research Sponsored by Colorado State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up this effect should be observable (1) at the week-4 post-test, (2) the week-8 post-test, and (3) the 6-month post-test.

Awards & highlights

Study Summary

This trial found that the AgingPLUS intervention increased physical activity among middle-aged and older adults.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this effect should be observable (1) at the week-4 post-test, (2) the week-8 post-test, and (3) the 6-month post-test.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this effect should be observable (1) at the week-4 post-test, (2) the week-8 post-test, and (3) the 6-month post-test.

This trial's timeline: 3 weeks for screening, Varies for treatment, and this effect should be observable (1) at the week-4 post-test, (2) the week-8 post-test, and (3) the 6-month post-test. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Increased physical activity

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Active Treatment GroupExperimental Treatment1 Intervention

This group will get the AgingPLUS intervention program which addresses negative views on aging, low internal control beliefs, and deficient goal planning skills.

Group II: Active Control GroupPlacebo Group1 Intervention

This group will get a generic health education program, called the "10 Keys to Healthy Aging". The control program will control for the effect of social contact and will not address the intervention targets of the active treatment group. The health education program will only provide information related to some of the most important health conditions, such as cardiovascular disease, cancer, type 2 diabetes, and clinical depression, and how these conditions can be managed.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

AgingPLUS

2018

N/A

~410

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Colorado State UniversityLead Sponsor

124 Previous Clinical Trials

37,852 Total Patients Enrolled

Johns Hopkins UniversityOTHER

2,250 Previous Clinical Trials

14,817,412 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,665 Previous Clinical Trials

28,004,677 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research experiment permit seniors seventy-five and over to participate?

"According to the inclusion criteria, this trial is available for patients aged 45-75. For those outside of this age range, there are 34 studies dedicated to individuals under 18 and 73 trials geared towards seniors over 65."

Answered by AI

Have applications for this trial ceased, or are they still being accepted?

"The records on clinicaltrials.gov allude to the fact that this research is presently not recruiting participants, despite being first posted in May 2018 and last edited in July 2022. Nevertheless, there are 112 other medical trials currently searching for volunteers at this moment."

Answered by AI

May I become a participant in this investigation?

"This clinical trial hopes to enrol 288 participants between the ages of 45 and 75 that meet certain requirements. Specifically, those applying must be open to randomization into one of two programs, agree to follow-up testing (i.e., not moving out of the area during the study period), participate in physical fitness tests, wear an accelerometer, and engage in less than 60 minutes of weekly physical activity with plans to start a program soon."

Answered by AI

Recent research and studies

Contemporary Clinical TrialsJournal

The Aging Trial: Design of a Randomized Controlled Trial to Increase Physical Activity in Middle-aged and Older Adults

Diehl, Manfred, Abigail Nehrkorn-Bailey, Katherine Thompson, Diana Rodriguez, Kaigang Li, George W. Rebok, David L. Roth, et al.. 2020. “The Aging Trial: Design of a Randomized Controlled Trial to Increase Physical Activity in Middle-aged and Older Adults”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2020.106105.

plusJournal

Feasibility and Efficacy of the Agingplus Program: Changing Views on Aging to Increase Physical Activity

Brothers, Allyson, and Manfred Diehl. 2017. “Feasibility and Efficacy of the Agingplus Program: Changing Views on Aging to Increase Physical Activity”. Journal of Aging and Physical Activity. Human Kinetics. doi:10.1123/japa.2016-0039.

clinicaltrials.govStudy

AgingPLUS: Promoting Physical Activity in Adults

Manfred Diehl, PhD 2018. "AgingPLUS: Promoting Physical Activity in Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03299348.